A newer GLP-1 receptor agonist, tirzepatide, demonstrates weight loss as high as 20% change in body weight compared with 3% in the placebo group in a RCT
This helps you recognize patterns (for example, many people find that egg aversions correlate specifically with dose escalation periods and resolve once the dose stabilizes) and plan reintroduction accordingly
Tirzepatide shows a smaller and more transient elevation
The drugs effect on hormone receptors might assist the body in seeking a more stable hormonal balance, which is significant in menopause
For researchers serious about getting their dose schedule right, SeekPeptides provides the most comprehensive peptide education platform available, with evidence-based protocols, dosing calculators, community support, and expert guidance that help you navigate every phase of the titration process with confidence
The opposite is generally true